Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
NCT05334940 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2024-08-21
Summary
The Atopy Registry aims to assess data about atopic disorders and their medical care in a standardized form. With this, the comparative efficacy, tolerability and safety of systemic therapies for atopic disorders should be investigated. An optional additional module "Bioanalytic" shall provide insights into further connections regarding immunology, genetics and microbiome.
Conditions
- Atopic Disorders
Interventions
- OTHER
-
not applicable, observational study
Patients do not receive intervention
Sponsors & Collaborators
-
Charite University, Berlin, Germany
lead OTHER
Principal Investigators
-
Margitta Worm, Prof. · Charite University, Berlin, Germany
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-08
- Primary Completion
- 2025-08-31
- Completion
- 2025-08-31
Countries
- Germany
Study Locations
More Related Trials
-
Impact of AIT on Allergic Rhinitis and Asthma
NCT04125888 ·Status: COMPLETED
-
Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.
NCT01795846 ·Status: UNKNOWN
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
NCT04915352 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
NCT00263640 ·Status: COMPLETED ·Phase: PHASE3
-
Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients
NCT05019209 ·Status: COMPLETED ·Phase: NA
-
Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy
NCT00540150 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)
NCT01549340 ·Status: COMPLETED
-
Local IgE in Subjects With Allergic or Non-allergic Rhinitis
NCT02810535 ·Status: COMPLETED ·Phase: NA
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid
NCT00540631 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574704 ·Status: COMPLETED ·Phase: PHASE2
-
Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects
NCT03039101 ·Status: COMPLETED ·Phase: NA
-
Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction.
NCT01134757 ·Status: COMPLETED ·Phase: NA
-
Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients
NCT03850626 ·Status: COMPLETED
-
Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00575003 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanisms of Anaphylaxis
NCT03182491 ·Status: ACTIVE_NOT_RECRUITING
-
Montelukast as a Controller of Atopic Syndrome
NCT00559546 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574223 ·Status: COMPLETED ·Phase: PHASE2
-
Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
NCT04314999 ·Status: COMPLETED
-
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
NCT04071249 ·Status: COMPLETED
-
A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria
NCT03436797 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Nasal Inflammatory Biomarkers
NCT03450031 ·Status: COMPLETED ·Phase: NA